6,600
Participants
Start Date
March 3, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
Continue DTG-based antiretroviral therapy
Participants will continue on DTG-based ART after enrollment for up to 12 months
Enhanced adherence counselling
Participants with VL ≥200 copies/mL will undergo enhanced adherence counselling
RECRUITING
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu
NOT_YET_RECRUITING
Bomu Hospital, Mombasa
RECRUITING
Butha-Buthe District Hospital, Butha-Buthe
RECRUITING
Mokhotlong District Hospital, Mokhotlong
NOT_YET_RECRUITING
CS Ponta Gea, Beira
NOT_YET_RECRUITING
CS Machava II, Maputo
NOT_YET_RECRUITING
CS Ndlavela, Maputo
NOT_YET_RECRUITING
MUHAS Clinical Trial Unit, Dar es Salaam
RECRUITING
Kenyatta National Hospital, Nairobi
Instituto Nacional de Saúde, Mozambique
OTHER_GOV
Muhimbili University of Health and Allied Sciences
OTHER
SolidarMed
OTHER
London School of Hygiene and Tropical Medicine
OTHER
University of Nairobi
OTHER